http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102198355-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
filingDate | 2018-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102198355-B1 |
titleOfInvention | Pharmaceutical composition comprising Cymbidium extracts for preventing or treating allergic diseases or contact |
abstract | The present invention relates to a pharmaceutical composition for the prevention and treatment of allergic diseases or contact dermatitis comprising a cymbidium extract as an active ingredient, an external preparation for the skin, a cosmetic composition and a health functional food, and more specifically, a cymbidium extract Is effective in inhibiting the secretion of allergic mast cells at low concentrations and allergic contact dermatitis induced by a delayed hypersensitivity antigen (DNCB (2.4-dinitrochlorobenzene)) in animal models of scratching, skin sensory, blood Since it exhibits a reducing effect on IgE, it can be usefully used as a pharmaceutical composition for preventing and treating allergic diseases or contact dermatitis, skin external preparations, cosmetic compositions and health functional foods. |
priorityDate | 2018-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.